Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing

Measuring total cell-free DNA (cfDNA) or cancer-specific mutations herein has presented as new tools in aiding the treatment of cancer patients. Studies show that total cfDNA bears prognostic value in metastatic colorectal cancer (mCRC) and that measuring cancer-specific mutations could supplement b...

Descripción completa

Detalles Bibliográficos
Autores principales: Demuth, Christina, Spindler, Karen-Lise Garm, Johansen, Julia S., Pallisgaard, Niels, Nielsen, Dorte, Hogdall, Estrid, Vittrup, Benny, Sorensen, Boe Sandahl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085225/
https://www.ncbi.nlm.nih.gov/pubmed/30086420
http://dx.doi.org/10.1016/j.tranon.2018.07.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085225/
https://www.ncbi.nlm.nih.gov/pubmed/30086420
http://dx.doi.org/10.1016/j.tranon.2018.07.013

Ejemplares similares